Cargando…
The value proposition of investigator‐initiated clinical trials conducted by networks
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986691/ https://www.ncbi.nlm.nih.gov/pubmed/33583043 http://dx.doi.org/10.5694/mja2.50935 |
Ejemplares similares
-
Strengthening the reporting of harms of all interventions in clinical trials
por: Abdel Shaheed, Christina, et al.
Publicado: (2022) -
Opportunities for eConsent to enhance consumer engagement in clinical trials
por: Zeps, Nikolajs, et al.
Publicado: (2020) -
Landscape of clinical trials across the pancreatic cancer care continuum: an Australian perspective
por: Khan, Nadia N, et al.
Publicado: (2022) -
High value health care is low carbon health care
por: Barratt, Alexandra L, et al.
Publicado: (2021) -
Assessing the value of precision medicine health technologies to detect and manage melanoma
por: Mahumud, Rashidul A, et al.
Publicado: (2022)